1. Association of Metabolic Syndrome with COVID-19 in the Republic of Korea
- Author
-
In-Hwan Oh, So-Youn Park, Woo-Hwi Jeon, and Jeong-Yeon Seon
- Subjects
Male ,Metabolic Syndrome ,medicine.medical_specialty ,Waist ,business.industry ,Endocrinology, Diabetes and Metabolism ,COVID-19 ,Odds ratio ,medicine.disease ,Logistic regression ,Confidence interval ,Risk Factors ,Diabetes mellitus ,Internal medicine ,Epidemiology ,Odds Ratio ,medicine ,Humans ,Female ,Waist Circumference ,Metabolic syndrome ,Risk factor ,business - Abstract
Background: Metabolic syndrome (MetS) is reportedly a crucial risk factor for coronavirus disease 2019 (COVID-19). Since the epidemiological studies that examine this association are few and include small samples, we investigated the relationship between MetS and COVID-19 severity and death using a larger sample in the Republic of Korea.Methods: We analyzed 66,321 patients, 4,066 of whom had COVID-19. We used chi-square tests to examine patients’ characteristics. We performed logistic regression analysis to analyze differences in COVID-19 infection and clinical outcomes according to the presence of MetS.Results: Although MetS was not significantly associated with COVID-19 risk, acquiring MetS was significantly associated with the risk of severe COVID-19 outcomes (odds ratio [OR], 1.97; 95% confidence interval [CI], 1.34 to 2.91; P=0.001). The mortality risk was significantly higher in COVID-19 patients with MetS (OR, 1.74; 95% CI, 1.17 to 2.59; P=0.006). Patients with abnormal waist circumference were approximately 2.07 times more likely to develop severe COVID-19 (PP=0.012).Conclusion: COVID-19 is likely associated with severity and death in patients with MetS or in patients with MetS risk factors. Therefore, patients with MetS or those with abnormal waist circumference and HDL-C levels need to be treated with caution.
- Published
- 2022
- Full Text
- View/download PDF